/

Sociétés

AM

Sociétés

AMSBIOPHARMA

Ce que nous écrivons

Auto / AutomobilePharmacieSantéSanté PubliqueUniversité

26 communiqués de presse

Voir tous les communiqués de presse

Press Release cover image

26/11/2025

Santé

Santé Publique

Accelerate Drug Development with Preclinical Contract Research | AMSbiopharma

Source

1.00

0

Press Release cover image

19/11/2025

Université

Santé

Santé Publique

Optimize LC‑MS/MS Sensitivity: Ion Suppression in Bioanalysis | AMSbiopharma

Source

1.00

0

Press Release cover image

29/10/2025

Santé

Santé Publique

Biomarkers for Bioanalytical Research in Drug Development | AMSbiopharma

Source

1.00

0

Press Release cover image

21/10/2025

Université

Santé

Santé Publique

How Mass Spectrometry enhances GMP quality control with LC‑MS | AMSbiopharma

Source

1.00

0

Press Release cover image

30/09/2025

Santé

Jeux

Ingénierie

AMSbiopharma completes its Innovation Plan, supported by Innova Pyme, achieving progress in services, technology, and entrepreneurial culture | AMSbiopharma

Source

1.00

0

Press Release cover image

22/09/2025

Santé

Santé Publique

Impurity profiling and HPLC methods for drug quality compliance | AMSbiopharma

Source

1.00

0

Press Release cover image

25/08/2025

Santé

Santé Publique

Pharma Quality Control in Drug Development and Compliance | AMSbiopharma

Source

1.00

0

Press Release cover image

11/08/2025

Santé

Santé Publique

Preclinical research strategies for drug development | AMSbiopharma

Source

1.00

0

Press Release cover image

22/07/2025

Université

Santé

Santé Publique

ICH Guidelines for Analytical Method Validation Explained | AMSbiopharma

Source

1.00

0

Press Release cover image

10/07/2025

Université

Santé

Santé Publique

Impurity guidelines in drug development under ICH Q3 | AMSbiopharma

Source

1.00

0

Followers

0

Compatibilité

0